
Jevity Powder

|
JevityŽ Powder
Specialised Feed
The advantages of JevityŽ in a cost effective and convenient
powder
Complete & balanced nutrition to help
improve patient nutrition status
 | Meets Institute of
Medicine guidelines for ratio of protein,
fats and carbohydrates in a healthy adult
diet 2 |
 | Meets American Heart
Association dietary guidelines for healthy
adults by providing only 30% of calories
from fat 3 |
Patented mixed-fiber/FOS system helps
improve GI tolerance
 | System blends soluble
(soy polysaccharide and oat fiber) and
insoluble fibers (gum arabic, carboxymethyl
cellulose and gellan gum), which can help
manage both mild-to-moderate constipation
4 and diarrhoea
5, 6 |
 | Fructooligosaccharides
(FOS) stimulate absorption of water and
electrolytes in the colon,5, 6
actions important for diarrhoea management 7 |
Therapeutic levels of FOS
(recommended at 10 g/day) help
maintain a healthy immune system and
inhibit growth of Clostridium
difficile bacteria in patients at
risk
 | FOS, a
prebiotic that promotes the
growth of beneficial bacteria
(e.g. bifidobacteria) in the
colon,8 which helps
maintain gastrointestinal tract
integrity and immune function
9, 10 |
 | Colonic
bacteria ferment FOS to
short-chain fatty acids, which
acidify the colon and create an
unfavorable environment for
growth of Clostridium difficile,
an intestinal pathogen
11 |
Easy to use, transport, and
store
 | Mixes at 0.5,
0.75 and 1.0 cal/ml
concentrations to help initiate
tube |
 | feeding in
patients |
 | Easier to
store and transport than liquid
feeds |
References
- Abbott
Laboratories. Institutional
Nutrition Tracking Study. Data
collected January through June
2008; 2008.
- Institute of Medicine.
http://www.iom.edu/board.asp?id=3788.
Dietary Reference Intakes for
Energy, Carbohydrate, Fiber,
Fat, Fatty Acids, Cholesterol,
Protein, and Amino Acids
(Macronutrients). 2005.
- Lichtenstein AH, Appel LJ,
Brands M, et al. Diet and
lifestyle recommendations
revision 2006. A scientific
statement from the American
Heart Association Nutrition
Committee. J Am Heart Assoc.
2006;114:82-96.
- Swennen K, Courtin C,
Delcour J. Non-digestible
oligosaccharides with prebiotic
properties. Crit Rev Food Sci
and Nutr. 2006;46:459-471.
- Bowling T, Raimundo A,
Grimble G, Silk D. Reversal by
short-chain fatty acids of
colonic fluid secretion induced
by enteral feeding. Lancet.
1993;342:1266-1268.
- Roberfroid M, Van Loo J,
Gibson G. The bifidogenic nature
of chicory inulin and its
hydrolysis products. J Nutr.
1998;128:11-19.
- Bartlett J.
Antibiotic-associated diarrhoea.
Infections of the
Gastrointestinal Tract. New
York: Raven Press; 1995:893-904.
- Bouhnik Y, Raskine L,
Simoneau G, Paineau D, Bornet F.
The capacity of short-chain
fructooligosaccharides to
stimulate faecal bifidobacteria:
a dose-response relationship
study in healthy humans. Nutr J.
2006;5:8.
- Gibson G, Roberfroid M.
Dietary modulation of the human
colonic microbiota—introducing
the concept of prebiotics. J
Nutr. 1995;125:1401-1412.
- Hosono A, Ozawa A, Kato R,
Ohnishi Y, Nakanishi Y, Kimura
T. Dietary
fructooligosaccharides induce
immunoregulation of intestinal
IgA secretion by murine Peyer’s
patch cells. Biosci Biotechnol
Biochem. 2003;67:758-764.
- May T, Mackie R, Fahley GJ,
Cremin J, Garleb K. Effect of
fiber sources on short-chain
fatty acid production and on the
growth an toxin production by
Clostridium difficile. Scand J
Gastroenterol. 1994;29:916-922.
|
|
|